UBX - Unity Biotechnology, Inc Net Margin

Official company branding of Unity Biotechnology (UBX)

Unity Biotechnology (UBX) sales margins demonstrate the success of a leader in creating senolytic molecules for the therapy of ocular pathologies. Business efficiency is bolstered by the implementation of robotic screening and software-based processing of research data. Furthermore, the development of anti-aging treatments provides access to an exclusive market niche with high pricing power, and the value of 0.00 corresponds to the current metric of this indicator.

Unity Biotechnology (UBX) Net Margin: for the period 07/04/2022 - 07/19/2025

Analytical breakdowns for Unity Biotechnology

Fundamental company analysis:Unity Biotechnology, Inc, UBX
Manufactured product of Unity Biotechnology Inc.

Net profit margin measures the portion of net income in every dollar of revenue, determining the ultimate efficiency of the operating model. This ratio allows investors to filter out volatile assets by assessing a business's ability to generate real income. By analyzing the net profit margin percentage on GURU.Markets, one can identify hidden overvaluation risks. For Unity Biotechnology (UBX), this indicator is critical due to the absence of commercial products. Negative price action here reflects the massive expenditures on clinical trials in the struggle against competitors.

Analysis of competing companies

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Net Margin|Applied DNA - Net Sales Margin|Net Margin Bluebird Bio|ImmunoPrecise (IPA) - Net Margin|Net Profit Margin OMGA (Omega)|Net Margin Singular Genomics Systems|Net Margin regulusrx.com RGLS|Net Margin Syros Pharmaceuticals Inc. (SYRS)|Company Sales Margin Codex DNA|Net Margin TRACON TCON